NCT01098214

Brief Summary

To provide rigorous, detailed normative data for diagnostics and comparative studies, to determine relationships between cytokine levels (and other biomarkers) and clinical data, and gain further insight into the pro-/anti-inflammatory cytokine profile of normal midtrimester amniotic fluid.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2010

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

1.6 years

First QC Date

April 1, 2010

Last Update Submit

May 17, 2019

Conditions

Keywords

Normal pregnancyAmniotic fluidCytokinesBiomarkers

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women undergoing amniocentesis with an apparently normal pregnancy

You may qualify if:

  • Age over 18
  • Pregnancies between 15-25 weeks gestation.
  • Able to provide informed consent.
  • No apparent major sonographic abnormality.

You may not qualify if:

  • Any major fetal anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Amniotic fluid samples from patients undergoing amniocentesis with an apparently normal pregnancy will have a small aliquot of fluid stored for future analysis, including the cytokine profile, proteomics, metabolomics, etc.

Study Officials

  • Nazeeh Hanna, M.D.

    Winthrop University Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2010

First Posted

April 2, 2010

Study Start

April 1, 2010

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

May 21, 2019

Record last verified: 2019-05